水凝胶及其在药物控释体系上的应用

智能水凝胶作为药物载体有着良好的应用前景。人体环境中存在一些变化的因素，如温度、pH。因此，温度敏感性水凝胶和pH敏感性水凝胶可用于药物在人体中的控释体系。本文主要介绍水凝胶材料的种类以及智能水凝胶在药物控释体系上的应用。     

智能水凝胶双抗癌药物控释体系

近年来,基于联合用药策略的双药物控释体系的研究为降低抗癌药物毒性和提高疗效提供了有效途径。水凝胶作为一类高临床应用价值的药物载体,在药物控释方面具有广泛的应用前景。癌症是危害人类健康和生命的疾病之一,当人体内正常细胞发生癌变后,癌变细胞周围会发生一些显著的变化。因此,根据肿瘤细胞与正常细胞在体内环境及体外环境的差异,发展了多种智能型水凝胶双抗癌药物控释载体。它能够在感知外界因素的刺激下发生内部结构的变化,从而实现对药物的可控释放。与此同时,随着新的治疗手段的兴起和更多抗癌作用靶点的发现,水凝胶载体也成功实现了化学药物和生物治疗因子的同时负载和可控释放。本文将从不同智能型水凝胶载体如何负载、控释双抗癌药物及水凝胶药物载体中药物的组合方式两方面综述智能型水凝胶双抗癌药物控释体系最新研究进展,并展望其发展前景。     

响应性凝胶及其在药物控释上的应用

综述近年来在响应性凝胶材料研究方面的进展，介绍了能感应ｐＨ、温度、光、电场以及生化物质等外界因素变化的响应性凝胶的结构特点与响应机理，同时介绍了此类凝胶应用于药物控制释放方面的研究近况。     

响应性水凝胶及其在生物医药领域应用研究进展

响应性水凝胶又称"智能水凝胶",是以水凝胶为基础,经修饰响应多种理化性质及微小环境变化,从而改变自身性质的一类水凝胶。响应性水凝胶目前广泛应用于生物医药领域、材料领域等,如:制备pH响应性水凝胶负载阿霉素(DOX)治疗癌症,温度响应性水凝胶制作3D生物打印材料用于创伤修复,葡萄糖响应性水凝胶治疗糖尿病足等。本文介绍了响应性水凝胶研究的国内外发展动态,包括响应性水凝胶的制备、修饰方法及其在生物医药领域的应用,并对未来的发展方向进行了讨论与展望。     

刺激响应性水凝胶在肿瘤治疗中的研究进展

恶性肿瘤的治疗在临床中一直备受关注,由于肿瘤细胞的浸润性和顽固性,常规治疗通常会产生严重的毒副作用。相较于全身化疗,局部载药水凝胶的使用显著降低了全身毒性并可实现药物在肿瘤部位的持续递送。此外,经物理掺杂或化学修饰的刺激响应性水凝胶,还可响应环境条件变化(如温度、pH、光等),实现原位交联和药物可控释放,大大提高了临床顺应性和药物递送效率。本综述分类讨论了用于肿瘤治疗的刺激响应性水凝胶的设计策略;汇总了近年来此类水凝胶的研究进展及其药物递送方案;并针对该领域存在的实际问题提出了可能的发展方向。     

智能高分子及水凝胶的响应性及其应用

结合一些范例综述了智能水凝胶的基本概念、种类以及智能高分子响应环境温度、pH值和光信号刺激的相转变行为, 简要介绍了该类高分子在农林业、卫生等领域中的应用, 并对其发展前景作了展望.     

智能纳米水凝胶的刺激响应性研究进展

智能纳米水凝胶在药物输送与可控释放、医学诊断、生物传感器、微反应器、催化剂载体等方面有良好的应用前景。结合本课题组近年来的研究成果,分别介绍了具有温度刺激响应性、pH刺激响应性、光刺激响应性、磁场刺激响应性、分子识别刺激响应性和多重刺激响应性智能纳米水凝胶的研究进展。另外,对这几种智能纳米水凝胶目前存在的问题和今后的发展方向提出了一些粗浅的看法。     

PNIPA类纳米水凝胶在药物缓控释研究中的应用

简要介绍了聚N-异丙基丙烯酰胺(Poly N-isopropylacrylamide, PNIPA)类纳米水凝胶的性质及智能响应机理,并重点综述了近年来此类纳米水凝胶在药物缓控释研究中的应用:作为脂溶性小分子药物的载体,达到增溶及缓控释药物的效果,并增强药物的稳定性及生物活性;作为水溶性小分子药物的载体,达到缓释该类药物的效果;作为生物大分子药物(蛋白,多糖)的载体,克服直接用药时的弊端;此外,还可作为基因工程载体.     

基于水凝胶体系的磷酸根响应控释农药释放行为分析

基于Fe³⁺与羧甲基纤维素钠(CMC)的交联作用,制备了以凹凸棒土(ATP)为载体、吡虫啉(IM)为目标农药分子的基于水凝胶的磷酸根(PO^3-₄)响应控释农药体系(PCRPH)。利用扫描电镜、X射线衍射等表征了PCRPH。结果表明,PCRPH与PO^3-₄相互作用,主要发生溶胀和Fe³⁺解离。随着PO^3-₄浓度增大,PCRPH中分子间距增加并逐步解离,能有效促进内部IM分子向外扩散,实现农药的可控释放,提高农药利用率。释放动力学分析表明,IM在PO^3-₄溶液中的释放过程属于Fickian扩散。此外,溶液中IM的释放量大小不受共存阴离子Cl^-及pH值的影响,具有良好的稳定性,但提高温度能促进IM从PCRPH中释放。     

聚膦腈在药物控释系统中的应用

聚膦腈由于其具有良好的生物相容性，可生物降解性及易于功能化的特性而成为一类独特的药物控释材料。本文就疏水性线型聚膦腈，聚膦腈水凝胶及聚膦腈高分子药物在药物控释系统中的应用作一简要综述。     

聚合物/SiO2杂化材料在药物控制释放中的应用*

聚合物用作药物控制释放载体时,具有释药浓度可控、药物的生物利用率高、可实现靶向治疗等优点。但有些聚合物也存在机械强度低、化学稳定性差、生物相容性不理想等缺点。二氧化硅(SiO₂)具有多孔、无毒、生物相容性好、化学和机械稳定性高、表面易功能化等优点。但SiO₂用作药物控制释放载体时,有时也存在载药量低、不能装载大分子药物、不能实现靶向释放等缺点。聚合物/SiO₂杂化材料作为药物控制释放载体,可有效结合二者的优点,并克服二者的缺陷。根据聚合物的种类和杂化体系性质的不同,我们分别对温敏性聚合物/SiO₂杂化材料、聚电解质/SiO₂杂化材料、生物高分子/SiO₂杂化材料以及其它一些聚合物/SiO₂杂化材料体系在药物控制释放中的应用进行了介绍,并展望了该领域今后的研究发展方向。     

控制释放技术

综述药物控制释放的种类，机理，高分子材料在控制释放技术中的应用。     

The Cyclodextrins as Modelling Agents of Drug Controlled Release

The controlled release of nicardipine (NC) was achieved by hybridizing its hydrophilic and hydrophobic cyclodextrin (CDs) complexes, i.e., those with hydroxypropyl--cyclodextrin (HPCD) andtriacetyl--cyclodextrin (TACD),respectively. ¹H-nuclearmagnetic resonance (¹H-NMR) was performed to examine the interaction between both CDs and NC in solution. The solid complexes of NC : HPCD and NC : TACD were prepared, in a 1 : 1 molar ratio by the spray-drying method. Complexation in the solid state was demonstrated by differential scanning calorimetry (DSC) and powder X-ray diffractometry. In vitro dissolution studies were carried out in simulated gastric (pH 1.2) and intestinal (pH 6.8) fluids, according to the USP basket method. The ¹H-NMR studies provided clear evidence of an interaction between the CDs and the aromatic rings of NC. The DSC thermograms of the solid complexes showed no endothermic peak due to NC melting and their diffraction pattern was completely diffuse, which suggested the formation of a novel type solid phase with an amorphous character. The low dissolution rate of NC, a weak basic drug, in alkaline medium was significantly improved by complexation with HPCD. In contrast, the in vitro release of this drug from the NC : TACD complexes was markedly retarded in both dissolution media. An optimal formulation was then designed by the combination, in different molar ratios, of these two complexes. The release behavior of these preparations was investigated and it was observed that the retarding effect was dependent on the amount of the NC : TACD complex. In addition, the initial release rate became faster as the molar ratio of the NC : HPCD complex increased.     

聚电解质复合物在药物控释中的应用

近年来聚电解质复合物在药物控释领域受到重视。对聚电解质复合物在响应型药物控释、细胞免疫隔离移植、多肽蛋白质药物的缓释及其基因治疗等领域的应用进行了综述。     

金粒子包封介孔二氧化硅杂化载药控释体系

靶向给药控释体系既可以增强药物在病灶部位的疗效, 又可以降低药物对正常部位的毒副作用. 基于介孔二氧化硅为"容器"-金纳米粒子为"开关"(MSN-AuNPs)的杂化纳米阀门体系同时具备两种纳米粒子的优良特性, 在化学、生物材料以及临床医药等多学科受到广泛关注. 本文根据刺激手段和应用功能分类, 介绍了单一功能和多重功能的MSN-AuNPs杂化纳米阀门体系的重要研究进展, 以及目前面临的挑战和今后的发展方向.     

Thermally Responsive Hydrogel Blends: A General Drug Carrier Model for Controlled Drug Release

Thermally responsive hydrogels have drawn significant research attention recently because of their simple use as drug carrier at human body temperature. Here we design a hybrid hydrogel that incorporates a hydrophilic polymer, polyethyleneimine (PEI), into the thermally responsive hydrogel poly(N‐isopropylacrylamide) (PNIPAm), as a general drug carrier model for controlled drug release. In this work, on one hand, PEI modifies the structure and the size of the pores in the PNIPAm hydrogel. On the other hand, PEI plays an important role in tuning the water content in the hydrogel and controls the water release rate of the hydrogel below the lower critical solution temperature (LCST), resulting in a tunable release rate of the drugs at human body temperature (37 °C). Different release rates are shown as different amounts of PEI are incorporated. PEI controls the release rate, dependent on the charge characteristics of the drugs. The hydrogel blends described in this work extend the concept of a general drug carrier for loading both positively and negatively charged drugs, as well as the controlled release effect.     

Ion Exchange Controlled Drug Release from Polymerized Ionic Liquids

In this work ion functionalized hydrogels as potent drug delivery systems are presented. The ion functionalization of the hydrogel enables the retention of ionic drug molecules and thus a reduction of burst release effects. Timolol maleate in combination with polymerized anionic 3‐sulfopropylmethacrylate potassium and ibuprofen combined with cationic poly‐[2‐(methacryloyloxy)ethyl] trimethylammonium chloride are investigated in respect to their drug release profile. The results are showing an ion exchange depending release behavior instead of a diffusion‐controlled drug release as it is known from common drug delivery systems. Furthermore, the suitability of such hydrogels for standard methods for sterilization is investigated.